3 Einträge gefunden

1. Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study

   1. Reich, Kristian
   2. Armstrong, April W
   3. Foley, Peter
   4. Song, Michael
   5. Miller, Megan
   6. Shen, Y K
   7. You, Yin

   2020 - Forschungsinformationssystem des UKE
2. Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials

   1. Reich, Kristian
   2. Griffiths, Christopher E M
   3. Gordon, Kenneth B
   4. Papp, Kim A
   5. Song, Michael
   6. Randazzo, Bruce
   7. Li, Shu

   2020 - Forschungsinformationssystem des UKE
3. Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumab

   1. Reich, Kristian
   2. Foley, Peter
   3. Han, Chenglong
   4. McElligott, Sean
   5. Muser, Erik
   6. Li, Nan
   7. Armstrong, April W

   2020 - Forschungsinformationssystem des UKE